These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22112354)

  • 21. Novel agents targeting nitric oxide.
    Kampoli AM; Tousoulis D; Tentolouris C; Stefanadis C
    Curr Vasc Pharmacol; 2012 Jan; 10(1):61-76. PubMed ID: 22112348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities.
    Thomas SR; Witting PK; Drummond GR
    Antioxid Redox Signal; 2008 Oct; 10(10):1713-65. PubMed ID: 18707220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
    Channon KM
    Trends Cardiovasc Med; 2004 Nov; 14(8):323-7. PubMed ID: 15596110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial dysfunction in normal and abnormal glucose metabolism.
    Esper RJ; Vilariño JO; Machado RA; Paragano A
    Adv Cardiol; 2008; 45():17-43. PubMed ID: 18230954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Free radicals, diabetes and endothelial dysfunction.
    Bayraktutan U
    Diabetes Obes Metab; 2002 Jul; 4(4):224-38. PubMed ID: 12099971
    [No Abstract]   [Full Text] [Related]  

  • 26. Endothelial dysfunction in diabetes.
    De Vriese AS; Verbeuren TJ; Van de Voorde J; Lameire NH; Vanhoutte PM
    Br J Pharmacol; 2000 Jul; 130(5):963-74. PubMed ID: 10882379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C.
    Antoniades C; Tousoulis D; Tountas C; Tentolouris C; Toutouza M; Vasiliadou C; Tsioufis C; Toutouzas P; Stefanadis C
    Diabet Med; 2004 Jun; 21(6):552-8. PubMed ID: 15154938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
    Antoniades C; Shirodaria C; Leeson P; Antonopoulos A; Warrick N; Van-Assche T; Cunnington C; Tousoulis D; Pillai R; Ratnatunga C; Stefanadis C; Channon KM
    Eur Heart J; 2009 May; 30(9):1142-50. PubMed ID: 19297385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences].
    Patti G; Melfi R; Di Sciascio G
    Recenti Prog Med; 2005 Oct; 96(10):499-507. PubMed ID: 16491775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial dysfunction in diabetes mellitus.
    Cosentino F; Lüscher TF
    J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S54-61. PubMed ID: 9883749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide bioavailability dysfunction involves in atherosclerosis.
    Chen JY; Ye ZX; Wang XF; Chang J; Yang MW; Zhong HH; Hong FF; Yang SL
    Biomed Pharmacother; 2018 Jan; 97():423-428. PubMed ID: 29091892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Endothelial function].
    Higashi Y; Yoshizumi M
    Nihon Rinsho; 2003 Jul; 61(7):1138-44. PubMed ID: 12877075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches.
    Tousoulis D; Simopoulou C; Papageorgiou N; Oikonomou E; Hatzis G; Siasos G; Tsiamis E; Stefanadis C
    Pharmacol Ther; 2014 Dec; 144(3):253-67. PubMed ID: 24928320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
    Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The main determinants of endothelial dysfunction].
    Garaliene V
    Medicina (Kaunas); 2006; 42(5):362-9. PubMed ID: 16778463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis.
    Schäfer A; Bauersachs J
    Curr Vasc Pharmacol; 2008 Jan; 6(1):52-60. PubMed ID: 18220940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
    Lin KY; Ito A; Asagami T; Tsao PS; Adimoolam S; Kimoto M; Tsuji H; Reaven GM; Cooke JP
    Circulation; 2002 Aug; 106(8):987-92. PubMed ID: 12186805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress, antioxidants, and endothelial function.
    Schulz E; Anter E; Keaney JF
    Curr Med Chem; 2004 May; 11(9):1093-104. PubMed ID: 15134508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.